What are the best large-cap cardiology pharmaceutical, biotech and medtech stocks to invest in right now? Seeking Alpha ...
Supira Medical has raised $120 million to complete the clinical development of its temporary heart pump, designed for ...
Abiomed is a medical device company headquartered in Danvers, Mass. Now part of Johnson & Johnson’s MedTech Segment, it ...
A U.S. court has brought back a patent infringement case between Getinge's Maquet and Johnson & Johnson's Abiomed.
The the Court of Justice for the European Union reports a decrease in new IP cases in 2024 despite a 12% increase in overall ...
Background The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with adverse ...
In a transformative recent study, the Second Heart Assist Inc. Whispertm device, a next-generation percutaneous mechanical circulatory support (pMCS) system, was shown to cause significantly less ...
system — caused significantly less hemolysis than the widely used Johnson & Johnson MedTech/Abiomed Impella CP when both pumps were operated at their maximum speeds. Second Heart Assist said its ...
Use of two high-risk cardiovascular devices—the Watchman (Boston Scientific) left atrial appendage occluder and the Impella (Abiomed) left ventricular assist device—is highest in the United States ...
As part of its restructuring, Adagio is pivoting to increase focus on its US pivotal trial. Image credit: Shutterstock / Andrii Yalanskyi. Adagio Medical has decided to reduce its workforce and pause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results